Work

Ikarugamycin inhibits pancreatic cancer cell glycolysis by targeting hexokinase 2

Year: 2020

Type: article

Source: The FASEB Journal

DOI: 10.1096/fj.201901237r

Authors: Shu‐Heng Jiang, Fang‐Yuan Dong, Lin‐Tai Da, Xiao‐Mei Yang, Xiao‐Xue Wang, Jing‐Yi Weng, Lei Feng, Li‐Li Zhu, Yan‐Li Zhang, Zhi‐Gang Zhang, Yong‐Wei Sun, Jun Li, Min‐Juan Xu

Institutions: Shanghai Jiao Tong University, Renji Hospital, Shanghai Cancer Institute, State Key Laboratory of Oncogene and Related Genes, Shanghai Medical College of Fudan University, Fudan University, Huadong Hospital

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Natural Science Foundation of China

Awards: G1000005266, G5717718982, G7903037993

OpenAlex ID: W2998743175

FWCI: 1.653

Cites: 43

Cited by: 43

Related to: 10